Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeptronic Diagnostics is the trade name used by KMZ Holdings for a non-invasive, cloud-based diagnostic platform intended for rapid whole-body medical assessment. The company describes its core product as a handheld probe that emits an electronic medical field, captures reflected signals from the body, and uploads large datasets to a proprietary cloud system for analysis and report generation. Marketing materials claim the system can generate results in minutes and support a broad range of diagnostic use cases, including metabolic, infectious disease, and general health screening applications. The company has also described a stripped-down SARS-CoV-2 testing configuration and related wearable monitoring concepts. Publicly available information appears limited to company materials, press releases, and patent-related references, with no clear evidence of commercial-scale deployment or advanced regulatory clearance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeptronic Diagnostics.